Click Here to return To Results

 

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis NEJM 348:14-23, Miller,D.H.,et al, 2003 See this aricle in Pubmed Article Abstract In a placebo-controlled trial, treatment with natalizumab led to fewer inflammatory brain lesions and fewer relapses over a six-month period in patients with relapsing multiple sclerosis.

Related Tags

(click to filter results - removes previous filter) gadolinium MRI MRI,abnormal MRI,contrast enhanced MRI,serial multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of natalizumab treatment of neurologic disorder

Click Here to return To Results